Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Amanda R. Patrick"'
Autor:
Pall Jonsson, Manuj Sharma, Seamus Kent, Ashley Jaksa, Liza Gibbs, Shaun Rowark, Stephen Duffield, Lynne Kincaid, Ayad K Ali, Amanda R Patrick, Priya Govil, Nicolle Gatto
Publikováno v:
BMJ Open, Vol 12, Iss 10 (2022)
Objective To compare real-world effectiveness and safety of direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation (AFib) for prevention of stroke.Study design and setting A comparative cohort study in UK general practice
Externí odkaz:
https://doaj.org/article/7ade8453ce874eabbae04f690b92a445
Autor:
Ashley Jaksa, Lisa Bloudek, Josh J. Carlson, Kanya Shah, Yilin Chen, Amanda R. Patrick, Avery McKenna, Jon D. Campbell
Publikováno v:
International Journal of Technology Assessment in Health Care. 38
Health technology assessment (HTA) agencies are considering adopting a lifecycle approach to assessments to address uncertainties in the evidence base at launch and to revisit the clinical and economic value of therapies in a dynamic clinical landsca
Autor:
Ashley Jaksa, Liza Gibbs, Seamus Kent, Shaun Rowark, Stephen Duffield, Manuj Sharma, Lynne Kincaid, Ayad K Ali, Amanda R Patrick, Priya Govil, Pall Jonsson, Nicolle Gatto
Publikováno v:
BMJ Open. 12:e064662
ObjectiveTo compare real-world effectiveness and safety of direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation (AFib) for prevention of stroke.Study design and settingA comparative cohort study in UK general practice d
Autor:
William Murk, Amanda R. Patrick, Jeremy A. Rassen, Sebastian Schneeweiss, Dorothee B. Bartels
Publikováno v:
Clinical Epidemiology
Jeremy A Rassen,1 Dorothee B Bartels,2 Sebastian Schneeweiss,1,3,4 Amanda R Patrick,1 William Murk1,5 1Aetion, Inc, New York, NY, USA; 2BI X GmbH, Ingelheim, Germany; 3Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hosp
Autor:
Elizabeth M. Garry, Jeremy A. Rassen, Patrice Verpillat, Shirley V. Wang, Amanda R. Patrick, Dorothee B. Bartels
Publikováno v:
Clinical Pharmacology & Therapeutics. 99:325-332
The scientific community and decision-makers are increasingly concerned about transparency and reproducibility of epidemiologic studies using longitudinal healthcare databases. We explored the extent to which published pharmacoepidemiologic studies u
Autor:
John D. Seeger, Elizabeth M. Garry, Olesya Zorina, Victoria G. Gillet, Dorothee B. Bartels, Sebastian Schneeweiss, Elisabetta Patorno, Amanda R. Patrick
Publikováno v:
Drug Safety. 38:295-310
A growing body of observational literature on the association between glucose-lowering treatments and all-cause mortality has been accumulating in recent years. However, many investigations present designs or analyses that inadequately address the me
Autor:
Keturah R. Faurot, M. Alan Brookhart, Michele Jonsson Funk, Laura C. Hanson, Amanda R. Patrick, Wendy Camelo Castillo, Til Stürmer, Virginia Pate
Publikováno v:
Pharmacoepidemiology and Drug Safety. 24:59-66
Purpose Estimating drug effectiveness and safety among older adults in population-based studies using administrative health care claims can be hampered by unmeasured confounding as a result of frailty. A claims-based algorithm that identifies patient
Publikováno v:
Journal of Bone and Mineral Research. 29:1667-1674
Fractures related to osteoporosis are associated with $20 billion in cost in the United States, with the majority of cost born by federal health-care programs, such as Medicare and Medicaid. Despite the proven fracture reduction benefits of several o
Autor:
Gregory W. Daniel, Rhonda L. Bohn, Joshua J. Gagne, Amanda R. Patrick, Niteesh K. Choudhry, Jun Liu, Sebastian Schneeweiss, Gayathri Sridhar, Jeremy A. Rassen
Publikováno v:
Drug Safety. 37:151-161
Methods for near-real-time monitoring of new drugs in electronic healthcare data are needed. In a novel application, we prospectively monitored ischemic, bleeding, and mortality outcomes among patients initiating prasugrel versus clopidogrel in routi
Autor:
John D. Seeger, Steven M. Brunelli, Shirley V. Wang, Joshua J. Gagne, Krista F. Huybrechts, Amanda R. Patrick, Kenneth J. Rothman
Publikováno v:
Pharmacoepidemiology and Drug Safety. 22:542-550
The validity of epidemiologic findings depends on the completeness and accuracy with which covariates are measured and taken into account. For some variables such as comorbid conditions or concurrent therapies, it is often not possible to distinguish